Using red light to improve blood flow in patients with peripheral artery disease

Red light mediated trafficking of microvesicles as a mechanism for vasodilation

NIH-funded research Birmingham VA Medical Center · NIH-10862586

This study is looking at how red light might help improve blood flow for people with peripheral artery disease (PAD) by encouraging the release of a helpful substance from tiny particles in the body, and it could lead to a new, easy treatment that doesn't require surgery.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBirmingham VA Medical Center NIH-funded
Lab location1 site (Birmingham, United States)
Project IDNIH-10862586 on NIH RePORTER

What this research studies

This research investigates how red light can stimulate the release of nitric oxide from microvesicles in the body, which may help improve blood flow in patients suffering from peripheral artery disease (PAD). The study aims to understand how this process works in both healthy individuals and those experiencing oxidative stress. By examining the effects of red light on blood vessels, the researchers hope to find a new, effective treatment for PAD that could reduce the need for invasive procedures. Patients may benefit from a non-invasive therapy that enhances blood circulation and alleviates symptoms associated with PAD.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with peripheral artery disease who experience symptoms related to poor blood circulation.

Not a fit: Patients with conditions unrelated to blood flow or those who do not have peripheral artery disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a novel, non-invasive treatment option for improving blood flow in patients with peripheral artery disease.

How similar studies have performed: Previous research has shown promising results using light therapy for improving blood flow, suggesting that this approach may be effective for treating PAD.

Where this research is happening

Birmingham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Atherosclerotic Cardiovascular Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.